FLUOROPASSIV
LIVE

Serial Number

79189100

Owner

VASCUTEK LIMITED

Attorney

Jeffrey H. Greger

Filing Date

Mar 31, 2016

Add to watchlist:

No watchlists yet
View on USPTO

FLUOROPASSIV Trademark

Serial Number: 79189100 • Registration: 5135131

FLUOROPASSIV is a trademark filed by VASCUTEK LIMITED on March 31, 2016. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

VASCUTEK LIMITED (31 trademarks)

Newmains Avenue
Inchinnan, Renfrewshire PA4 9RR , GB

Entity Type: 11

Trademark Details

Filing Date

March 31, 2016

Registration Date

February 7, 2017

Published for Opposition

November 22, 2016

Cancellation Date

August 18, 2023

Goods & Services

Surgical apparatus and instruments; medical apparatus and instruments for use in cardiovascular procedures; prosthetic vascular grafts; prosthetic endovascular grafts; stents, vascular prostheses; vascular prostheses with flared outflow; vascular prostheses with customisable outflow; prosthetic vascular woven grafts; prosthetic endovascular knitted grafts; expanded polytetrafluoroethylene (ePTFE) vascular grafts; surgical implants comprising prosthetic materials; suture materials; patches for repair and reconstruction of internal tissue, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; implantable medical systems, namely, cardiac valves for surgical prostheses, stents, prosthetic vascular grafts, vascular prostheses, prosthetic vascular grafts, prosthetic endovascular grafts, and catheters; implantable medical devices, namely, implants consisting of prosthetic materials, synthetic vascular prostheses, prosthetic vascular grafts, and synthetic heart valve conduits; prosthetic vascular grafts; prosthetic endovascular grafts; surgical graft materials, namely, prosthetic vascular grafts, and vascular prostheses for the treatment of aneurysmal or occlusive arterial disease; medical devices for use in endovascular procedures, namely, medical devices for use in treating cardiovascular disease; synthetic thoracic stents; synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising more than one component comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising components of more than one stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; stent graft systems comprising components of more than one type of stent graft comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; thoracic stent graft systems comprised of synthetic stent grafts, stent delivery systems, and stent graft delivery systems; prosthetic systemic vascular grafts; prosthetic vascular straight grafts; prosthetic vascular abdominal grafts; prosthetic vascular thoracic grafts; prosthetic vascular branched grafts; prosthetic vascular pre-curved grafts; prosthetic vascular aortic arch grafts; prosthetic vascular branched arch grafts; delivery systems for synthetic stent graft systems comprised of medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; aneurysm repair systems comprised of catheter delivered stent grafts, medical instruments for intraluminal emplacement of stents or stent systems or of synthetic stent grafts, namely, stent delivery systems or stent graft delivery systems or synthetic stent graft delivery systems; medical devices, namely, aneurysm repair devices; cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, prosthetic cardiac valves; heart valves, namely, prosthetic heart valves; heart valve conduits, namely, catheters for implanting heart valves; cardiac patches, namely, cardiovascular patches, pericardial patches, and carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; vascular patches, namely, cardiovascular patches, pericardial patches, and carotid patches, surgical mesh comprised primarily of prosthetic materials; thin wall cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; thin wall carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; fluoropolymer cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; fluoropolymer carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; knitted cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; knitted carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; gelatin sealed cardiovascular patches, namely, surgical mesh comprised primarily of prosthetic materials; gelatin sealed carotid patches, namely, surgical mesh comprised primarily of prosthetic materials; parts and fittings for all of the aforementioned goods

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
May 21, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 30, 2024 INTS
INVALIDATION PROCESSED
Apr 30, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 18, 2024 INTR
CANCELLED SECTION 71
Aug 18, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 7, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 24, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 3, 2017 FICS
FINAL DISPOSITION PROCESSED
Jun 3, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 7, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 7, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 22, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 22, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 2, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 17, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 13, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 22, 2016 CRFA
ASSIGNED TO LIE
Sep 17, 2016 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 8, 2016 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2016 TROA
REFUSAL PROCESSED BY IB
Aug 5, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 20, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jul 20, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 20, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jul 19, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 19, 2016 MAFR
ASSIGNED TO EXAMINER
Jul 15, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 14, 2016 REPR